心脏病学
内科学
医学
射血分数
无症状的
斑点追踪超声心动图
亚临床感染
心肌梗塞
舒张期
心肌炎
收缩性
冠状动脉疾病
瓣膜性心脏病
心力衰竭
血压
作者
Roberta Lotti,Vincenzo De Marzo,Roberta Della Bona,Italo Porto,Gian Marco Rosa
出处
期刊:Minerva Medica
[Edizioni Minerva Medica]
日期:2022-01-20
卷期号:114 (4)
被引量:19
标识
DOI:10.23736/s0026-4806.21.07317-1
摘要
Echocardiographic evaluation of left ventricular ejection fraction (LVEF) provides important information regarding both myocardial function and prognosis. This parameter presents various limitations and does not allow early detection of myocardial dysfunction. LVEF may be related to hemodynamic load, geometric assumptions, to image quality, and it does not reflect myocardial contractility. It has been hypothesized that speckle tracking echocardiography (STE) may allow overcoming such limits. STE through the measurement of strain and strain rate, which detect myocardial deformation, allows earlier identification of myocardial dysfunction in different settings both in presence of systolic and diastolic dysfunction, helps to predict left ventricular remodeling after acute myocardial infarction (AMI), and helps to decide the timing of surgery in asymptomatic severe valvular heart disease which is still a problematic issue. Increasingly interest regards the role of STE for the assessment of cardiomyopathies, myocarditis, and pulmonary hypertension. STE may be applied to the evaluation of systolic and diastolic dysfunction. STE is useful in all conditions in which cardiac dysfunction is not still overt, but a subclinical involvement is undoubtedly present such as in presence of cardiovascular risk factors and in cardio-oncology at earlier stages. It has been confirmed its role in predicting left ventricular remodeling after AMI which represents an important prognostic datum and in deciding the timing of surgery in asymptomatic valvular diseases. STE is an important tool to detect myocardial impairment even at earlier stages. 3DSTE and layer-specific strain represent promising fields of clinical application of STE.
科研通智能强力驱动
Strongly Powered by AbleSci AI